Ardelyx, Inc. (NASDAQ:ARDX) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers. On June 18, H.C. Wainwright began coverage on...
9 hours ago

NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. ("Ardelyx" or the...
5 days ago

Ardelyx ( ($ARDX) ) has shared an announcement. On June 18, 2025, Ardelyx, Inc. held its Annual Meeting where stockholders approved an...
1 week ago

US cardiorenal-focussed drugmaker Ardelyx (Nasdaq: ARDX) announced that Mike Kelliher, formerly executive vice president,...
3 weeks ago

“To be truly dedicated,” Ardelyx Chief Executive Officer Mike Raab says, “you have to have some fearlessness. To be inclusive, you have to...
2 weeks ago

Ardelyx Inc. (NASDAQ:ARDX) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. On May 2, Leerink Partners analyst...
4 days ago

Ardelyx, Inc. ( NASDAQ:ARDX ) shareholders (or potential shareholders) will be happy to see that the Independent...
1 month ago

Ardelyx (ARDX) delivered earnings and revenue surprises of -70% and 8.14%, respectively, for the quarter ended March 2025.
1 month ago

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 ... Ardelyx (NASDAQ: ARDX), a biopharmaceutical company focused on...
1 month ago

Matthew Caufield, an analyst from H.C. Wainwright, has initiated a new Buy rating on Ardelyx (ARDX). Matthew Caufield has given his Buy rating due to a...
1 week ago